[3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy
Identifieur interne : 004F15 ( Main/Exploration ); précédent : 004F14; suivant : 004F16[3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy
Auteurs : Sophie Holemans [Belgique] ; France Javoy [France] ; Yves Agid [France] ; E. Christian Laterre [Belgique] ; Jean-Marie Maloteaux [Belgique]Source :
- Brain Research [ 0006-8993 ] ; 1991.
English descriptors
- KwdEn :
Abstract
The interactions existing between glutamatergic and dopaminergic systems, notably in the basal ganglia, suggest that glutamatergic antagonists may have therapeutic interest in extrapyramidal disorders characterized by impaired dopaminergic transmission. The binding of [3H]dizocilpine maleate (MK-801) to glutamate receptors of the N-methyl-d-aspartate (NMDA)-subtypes was characterized in temporal and frontal cortex, in hippocampus and in subcortical areas (caudate nucleus and putamen) from controls and patients with Parkinson's disease or progressive supranuclear palsy. The binding affinity (KD) and the maximal specific binding capacity (Bmax) of [3H]MK-801 were unchanged in all the cerebral regions studied in both disease. This indicates the existence of preserved NMDA glutamate receptors, which is required for potential therapeutic efficacy of specific antagonists.
Url:
DOI: 10.1016/0006-8993(91)91747-O
Affiliations:
- Belgique, France
- Province du Brabant wallon, Région wallonne, Île-de-France
- Louvain-la-Neuve, Paris
- Hôpital de la Salpêtrière, Université catholique de Louvain
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000548
- to stream Istex, to step Curation: 000548
- to stream Istex, to step Checkpoint: 001D55
- to stream Main, to step Merge: 005974
- to stream Main, to step Curation: 004F15
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">[3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy</title>
<author><name sortKey="Holemans, Sophie" sort="Holemans, Sophie" uniqKey="Holemans S" first="Sophie" last="Holemans">Sophie Holemans</name>
</author>
<author><name sortKey="Javoy, France" sort="Javoy, France" uniqKey="Javoy F" first="France" last="Javoy">France Javoy</name>
</author>
<author><name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation><country>France</country>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
<author><name sortKey="Laterre, E Christian" sort="Laterre, E Christian" uniqKey="Laterre E" first="E. Christian" last="Laterre">E. Christian Laterre</name>
</author>
<author><name sortKey="Maloteaux, Jean Marie" sort="Maloteaux, Jean Marie" uniqKey="Maloteaux J" first="Jean-Marie" last="Maloteaux">Jean-Marie Maloteaux</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E84A3C69F12B98A24C9A2D9AFD53ACE76817ACA4</idno>
<date when="1991" year="1991">1991</date>
<idno type="doi">10.1016/0006-8993(91)91747-O</idno>
<idno type="url">https://api.istex.fr/document/E84A3C69F12B98A24C9A2D9AFD53ACE76817ACA4/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000548</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000548</idno>
<idno type="wicri:Area/Istex/Curation">000548</idno>
<idno type="wicri:Area/Istex/Checkpoint">001D55</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001D55</idno>
<idno type="wicri:doubleKey">0006-8993:1991:Holemans S:h:mk:binding</idno>
<idno type="wicri:Area/Main/Merge">005974</idno>
<idno type="wicri:Area/Main/Curation">004F15</idno>
<idno type="wicri:Area/Main/Exploration">004F15</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">[3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy</title>
<author><name sortKey="Holemans, Sophie" sort="Holemans, Sophie" uniqKey="Holemans S" first="Sophie" last="Holemans">Sophie Holemans</name>
<affiliation wicri:level="4"><country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratoire de Neurochimie, Université Catholique de Louvain</wicri:regionArea>
<placeName><settlement type="city">Louvain-la-Neuve</settlement>
<region type="region" nuts="1">Région wallonne</region>
<region type="province" nuts="1">Province du Brabant wallon</region>
</placeName>
<orgName type="university">Université catholique de Louvain</orgName>
</affiliation>
</author>
<author><name sortKey="Javoy, France" sort="Javoy, France" uniqKey="Javoy F" first="France" last="Javoy">France Javoy</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Médecine Expérimentale, INSERM U 289, CHU Pitié-Salpêtrière, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Médecine Expérimentale, INSERM U 289, CHU Pitié-Salpêtrière, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
<placeName><settlement type="city">Paris</settlement>
<region type="region" nuts="2">Île-de-France</region>
</placeName>
<orgName type="hospital" n="4">Hôpital de la Salpêtrière</orgName>
</affiliation>
</author>
<author><name sortKey="Laterre, E Christian" sort="Laterre, E Christian" uniqKey="Laterre E" first="E. Christian" last="Laterre">E. Christian Laterre</name>
<affiliation wicri:level="4"><country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratoire de Neurochimie, Université Catholique de Louvain</wicri:regionArea>
<placeName><settlement type="city">Louvain-la-Neuve</settlement>
<region type="region" nuts="1">Région wallonne</region>
<region type="province" nuts="1">Province du Brabant wallon</region>
</placeName>
<orgName type="university">Université catholique de Louvain</orgName>
</affiliation>
</author>
<author><name sortKey="Maloteaux, Jean Marie" sort="Maloteaux, Jean Marie" uniqKey="Maloteaux J" first="Jean-Marie" last="Maloteaux">Jean-Marie Maloteaux</name>
<affiliation wicri:level="4"><country xml:lang="fr">Belgique</country>
<wicri:regionArea>Correspondence: J.-M. Maloteaux, Laboratoire de Neurochimie et Service de Neurologie (1352), Université Catholique de Louvain, Avenue Hippocrate, 10, B-1200 Brussels</wicri:regionArea>
<orgName type="university">Université catholique de Louvain</orgName>
<placeName><settlement type="city">Louvain-la-Neuve</settlement>
<region type="region" nuts="1">Région wallonne</region>
<region type="province" nuts="1">Province du Brabant wallon</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratoire de Neurochimie, Université Catholique de Louvain</wicri:regionArea>
<placeName><settlement type="city">Louvain-la-Neuve</settlement>
<region type="region" nuts="1">Région wallonne</region>
<region type="province" nuts="1">Province du Brabant wallon</region>
</placeName>
<orgName type="university">Université catholique de Louvain</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Brain Research</title>
<title level="j" type="abbrev">BRES</title>
<idno type="ISSN">0006-8993</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1991">1991</date>
<biblScope unit="volume">565</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="154">154</biblScope>
<biblScope unit="page" to="157">157</biblScope>
</imprint>
<idno type="ISSN">0006-8993</idno>
</series>
<idno type="istex">E84A3C69F12B98A24C9A2D9AFD53ACE76817ACA4</idno>
<idno type="DOI">10.1016/0006-8993(91)91747-O</idno>
<idno type="PII">0006-8993(91)91747-O</idno>
<idno type="ArticleID">9191747O</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0006-8993</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Glutamate antagonist</term>
<term>Human brain</term>
<term>N-methyl-d-aspartate receptors</term>
<term>Parkinson's disease</term>
<term>Progressive supranuclear palsy</term>
<term>[3H]Dizocilpine maleate</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The interactions existing between glutamatergic and dopaminergic systems, notably in the basal ganglia, suggest that glutamatergic antagonists may have therapeutic interest in extrapyramidal disorders characterized by impaired dopaminergic transmission. The binding of [3H]dizocilpine maleate (MK-801) to glutamate receptors of the N-methyl-d-aspartate (NMDA)-subtypes was characterized in temporal and frontal cortex, in hippocampus and in subcortical areas (caudate nucleus and putamen) from controls and patients with Parkinson's disease or progressive supranuclear palsy. The binding affinity (KD) and the maximal specific binding capacity (Bmax) of [3H]MK-801 were unchanged in all the cerebral regions studied in both disease. This indicates the existence of preserved NMDA glutamate receptors, which is required for potential therapeutic efficacy of specific antagonists.</div>
</front>
</TEI>
<affiliations><list><country><li>Belgique</li>
<li>France</li>
</country>
<region><li>Province du Brabant wallon</li>
<li>Région wallonne</li>
<li>Île-de-France</li>
</region>
<settlement><li>Louvain-la-Neuve</li>
<li>Paris</li>
</settlement>
<orgName><li>Hôpital de la Salpêtrière</li>
<li>Université catholique de Louvain</li>
</orgName>
</list>
<tree><country name="Belgique"><region name="Région wallonne"><name sortKey="Holemans, Sophie" sort="Holemans, Sophie" uniqKey="Holemans S" first="Sophie" last="Holemans">Sophie Holemans</name>
</region>
<name sortKey="Laterre, E Christian" sort="Laterre, E Christian" uniqKey="Laterre E" first="E. Christian" last="Laterre">E. Christian Laterre</name>
<name sortKey="Maloteaux, Jean Marie" sort="Maloteaux, Jean Marie" uniqKey="Maloteaux J" first="Jean-Marie" last="Maloteaux">Jean-Marie Maloteaux</name>
<name sortKey="Maloteaux, Jean Marie" sort="Maloteaux, Jean Marie" uniqKey="Maloteaux J" first="Jean-Marie" last="Maloteaux">Jean-Marie Maloteaux</name>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Javoy, France" sort="Javoy, France" uniqKey="Javoy F" first="France" last="Javoy">France Javoy</name>
</region>
<name sortKey="Agid, Yves" sort="Agid, Yves" uniqKey="Agid Y" first="Yves" last="Agid">Yves Agid</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004F15 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004F15 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:E84A3C69F12B98A24C9A2D9AFD53ACE76817ACA4 |texte= [3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |